Transvaginal sonography to observe the effects of tamoxifen on the endometrium - Efficacy and clinical aspects;Klinische Relevanz sonomorphologischer Veranderungen des endometriums unter Tamoxifentherapie

Geburtshilfe und Frauenheilkunde

Volumn 57, Issue 7, 1997, Pages 371-375

  Obwegeser, R ^a   Chalubinsky, K ^a   Turnheim, K ^a   Auerbach, L ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; TRANSVAGINAL ECHOGRAPHY; ULTRASOUND;

EID: 0030807103     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023101     Document Type: Article

References (26)

1. Andolf, E., K. Dahlander, P. Aspenberg: Ultrasonic thickness of the endometrium correlated to body weight in asymptomatic postmenopausal women. Obstet. Gynecol. 82 (1993) 936 - 940.
2. Anteby, E., S. Yagel, D. Zagut, Z. Palti, D. Hochner-Celnikier: False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen. Lancet 340 (1992) 433 - 434.
3. Baum, M., D. Brinkley, J. Dasset: Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer. Brit. J. Cancer 57 (1988) 608 - 611.
4. Ciatto, S., S. Cecchini, R. Bonardi, G. Grazzini: Ultrasonography surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet 344 (1994) 60.
5. Cohen, I., D. Rosen, R. Tepper, M. Cordoba, Y. Shapira, M. Altaras, D. Yegael, Y. Beyth: Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J. Ultrasound med. 5 (1993) 275 - 280.
6. Cohen, I., D. Rosen, J. Shapira, M. Cordoba, S. Gilboa, M. Altaras, D. Yigael, Y. Beyth: Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatik, postmenopausal breast cancer patients. Gynecol. Oncol. 52 (1994) 185 - 190.
7. Cohen, I., J. Shapira, M. Altaras, M. Cordoba, D. Rosen, Y. Beyth: Endometrial decidual changes in a postmenopausal women treated with tamoxifen and megestrol acetate. Brit. J. Obstet. Gynecol. 99 (1992) 773 - 774.
8. Cohen, I., J. Rosen, J. Shapira, M. Cordoba, S. Gilboa, M. Altaras, D. Yigael, Y. Beyth: Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Brit. J. Obstet Gynecol. 100 (1993) 567 - 570.
9. Corley, D., J. Rowe, M. Curtis, M. Hogan, J. Noumoff, V. Livolsi: Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet. Gynecol. 79 (1992) 111 - 116.
10. Cross, S., S. Ismail: Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Brit. J. Obstet. Gynaec0l. 97 (1990) 190 - 192.
11. Fornander, T., L. Rutqvist, B. Cedermark, U. Glas, A. Mattson, J. Silversward, L. Skoog, A. Somell, T. Theve, N. Wilking, J. Askergren, M. Hjalmar: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 2 (1989) 117 - 120.
12. Gal, D., S. Kopel, M. Bashevkin, J. Lebowitz, R. Lev, L. Tancer: Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer - preliminary report. Gynecol. Oncol. 42 (1991) 120 - 123.
13. Goldstein, S., M. Nachtigall, R. Snyder, L. Nachtigall: Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Amer. J. Obstet. Gynecol. 163 (1990) 119 - 123.
14. Granberg, S., M. Wikland, B. Karlsson, A. Norström, L. Friberg: Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Amer. J. Obstet. Gynecol. 164 (1991) 47 - 52.
15. Hulka, C., D. Hall: Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. AJR 160 (1993) 809 - 812.
16. Kedar, R., T. Bourne, T. Powles, W. Collins, S. Ashley, D. Cosgrove, S. Campbell: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343 (1994) 1318 - 1321.
17. Killackey, M., T. Hakes, V. Pierce: Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treatm. Rep. 69 (1985) 237 - 238.
18. Lahti, E., G. Blanco, A. Kauppila, M. Apaja-sarkkinen, P. Taskinen, T. Laatikainen: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet. Gynecol. 81 (1993) 660 - 664.
19. Van Leeuwen, F., J. Benraadt, J. Coebergh, L. Kiemeney, C. Gimbrère, R. Otter, L. Schouten, R. Damhuis, M. Bontenbal, F. Diepenhorst, A. Van den Beit-Dusebout, H. Van Tinteren: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343 (1994) 448 - 452.
20. Logmans, A., H. Mous, M. Bontenbal, H. Beerman, M. VanLent: Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma. Europ. J. Obstet Gynecol. 56 (1994) 173 - 176.
21. Nasri, M., G. Coast: Correlation of ultrasound findings and endometrial histopathology in postmenopausal women. Brit. J. Obstet. Gynaecol. 96 (1989) 1333 - 1338.
22. Nasri, M., J. Shepherd, M. Setchell, D. Lowe, T. Chard: The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Brit. J. Obstet Gynaecol. 98 (1991) 470 - 475.
23. Neven, P., X. De Muylder, Y. Van Belle, G. Vanderik, E. De Muylder: Tamoxifen and the uterus and endometrium. Lancet 1 (1989) 375.
24. Nuovo, M., G. Nuovo, R. McCaffrey, R. Levine, B. Barron, B. Winkler: Endometrial polyps in postmenopausal patients receiving tamoxifen. Int. J. gynecol. Pathol. 8 (1989) 125 - 131.
25. Patterson, J., L. Battersby: Tamoxifen: a review of recent studies in the field of oncology. Cancer Treatm. Rep. 64 (1980) 775 - 778.
26. Powles, T.: The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 340 (1992) 1145 - 1147.